Where should we draw the lines between dinocyst “species”? Morphological continua in Black Sea dinocysts

by T. M. Hoyle, M. Sala-Pérez, F. Sangiorgi
Published 2019-04-01

Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK

by M Hoyle, L Crathorne, R Garside, C Hyde
Published 2011-05-01

Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer

by M Bond, M Hoyle, T Moxham, M Napier, R Anderson
Published 2009-09-01

The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model

by M Bond, M Pitt, J Akoh, T Moxham, M Hoyle, R Anderson
Published 2009-08-01

Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.

by G Rogers, M Hoyle, J Thompson Coon, T Moxham, Z Liu, M Pitt, K Stein
Published 2012-04-01

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation

by J Thompson Coon, M Hoyle, C Green, Z Liu, K Welch, T Moxham, K Stein
Published 2010-01-01

Pesticide Contamination of Milkweeds Across the Agricultural, Urban, and Open Spaces of Low-Elevation Northern California

by Christopher A. Halsch, Aimee Code, Sarah M. Hoyle, James A. Fordyce, Nicolas Baert, Matthew L. Forister
Published 2020-06-01

The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (mon...

by M Hoyle, L Crathorne, J Peters, T Jones-Hughes, C Cooper, M Napier, P Tappenden, C Hyde
Published 2013-04-01

The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model

by M Bond, S Mealing, R Anderson, J Elston, G Weiner, RS Taylor, M Hoyle, Z Liu, A Price, K Stein
Published 2009-09-01

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a...

by M Bond, G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, S Davis, P Thokala, A Wailoo, M Jeffreys, C Hyde
Published 2012-04-01

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses.

by T Pavey, M Hoyle, O Ciani, L Crathorne, T Jones-Hughes, C Cooper, L Osipenko, M Venkatachalam, C Rudin, O Ukoumunne, R Garside, R Anderson
Published 2012-11-01